Unknown

Dataset Information

0

Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion.


ABSTRACT: Although the role of PD-L1 in suppressing the anti-tumor immune response is extensively documented, recent discoveries indicate a distinct tumor-intrinsic role for PD-L1 in modulating epithelial-to-mesenchymal transition (EMT), cancer stem cell (CSC)-like phenotype, metastasis and resistance to therapy. In this review, we will focus on the newly discovered functions of PD-L1 in the regulation of cancer development, describe underlying molecular mechanisms responsible for PD-L1 upregulation and discuss current insights into novel components of PD-L1 signaling. Furthermore, we summarize our current understanding of the link between PD-L1 signaling and the EMT program as well as the CSC state. Tumor cell-intrinsic PD-L1 clearly contributes to cancer stemness, EMT, tumor invasion and chemoresistance in multiple tumor types. Conversely, activation of OCT4 signaling and upregulation of EMT inducer ZEB1 induce PD-L1 expression in cancer cells, thereby suggesting a possible immune evasion mechanism employed by cancer stem cells during metastasis. Our meta-analysis demonstrated that PD-L1 is co-amplified along with MYC, SOX2, N-cadherin and SNAI1 in the TCGA endometrial and ovarian cancer datasets. Further identification of immune-independent PD-L1 functions and characterization of crucial signaling events upstream or downstream of PD-L1 in diverse cancer types and specific cancer subtypes, would provide additional targets and new therapeutic approaches.

SUBMITTER: Dong P 

PROVIDER: S-EPMC6156376 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion.

Dong Peixin P   Xiong Ying Y   Yue Junming J   Hanley Sharon J B SJB   Watari Hidemichi H  

Frontiers in oncology 20180919


Although the role of PD-L1 in suppressing the anti-tumor immune response is extensively documented, recent discoveries indicate a distinct tumor-intrinsic role for PD-L1 in modulating epithelial-to-mesenchymal transition (EMT), cancer stem cell (CSC)-like phenotype, metastasis and resistance to therapy. In this review, we will focus on the newly discovered functions of PD-L1 in the regulation of cancer development, describe underlying molecular mechanisms responsible for PD-L1 upregulation and d  ...[more]

Similar Datasets

| S-SCDT-EMBOJ-2018-99506 | biostudies-other
| S-EPMC5992436 | biostudies-literature
| S-EPMC6589543 | biostudies-literature
| S-EPMC6287426 | biostudies-other
2024-01-24 | PXD046384 | Pride
| S-EPMC9018773 | biostudies-literature
| S-EPMC9888393 | biostudies-literature
| S-SCDT-10_1038-S44318-024-00201-6 | biostudies-other
| S-EPMC7190922 | biostudies-literature
| S-EPMC6280658 | biostudies-literature